Prior to approval, as part of FDA’s evaluation, FDA takes all of the ingredients of a vaccine into account. After FDA approves a vaccine, FDA continuously monitors its safety.
Aluminum salts are incorporated into some vaccine formulations as an adjuvant. An adjuvant is a substance added to some vaccines to enhance the immune response of vaccinated individuals. The aluminum salts in some FDA-approved vaccines are aluminum hydroxide, aluminum phosphate, alum (potassium aluminum sulfate), or mixed aluminum salts. For example: aluminum salts are used in DTaP vaccines, the pneumococcal conjugate vaccine, the HPV vaccine, and hepatitis B vaccines.
Aluminum adjuvant containing vaccines have a demonstrated safety profile of over many decades of use and have only uncommonly been associated with severe local reactions. Of note, the most common source of exposure to aluminum is from eating food or drinking water.
Yes.
One vaccine for the prevention of H5N1 influenza, commonly referred to as avian influenza or “bird flu,” contains the adjuvant AS03, an oil-in-water emulsion. The AS03 adjuvant is made up of the oily compounds, D,L-alpha-tocopherol (vitamin E) and squalene, and an emulsifier, polysorbate 80, which helps ingredients mix together and keep them from separating, and water containing small amounts of salts. The vaccine is not commercially available, but included within the U.S. government’s Strategic National Stockpile if public health officials determine it is needed.
Fluad, a vaccine for the prevention of seasonal influenza in individuals 65 years of age and older, contains MF59, also an oil-in-water emulsion of squalene oil.
Heplisav-B, a vaccine for the prevention of infection caused hepatitis B virus in individuals 18 years of age and older, contains CpG 1018. Cyfendus, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis (Anthrax) in individuals 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs, contains CpG 7909. Both CpG 1018 and CpG 7909 are adjuvants based on synthetic DNA sequences. Cyfendus is included in the Strategic National Stockpile to be used for post-exposure prophylaxis with antibiotics in the event of a terrorist attack with anthrax.
Shingrix, a vaccine for the prevention of shingles in individuals 50 years of age and older, contains AS01B. Arexvy, a vaccine for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older, contains AS01E. Both AS01B and AS01E are made of up MPL, a purified fat-like substance, and QS-21 which is purified from the bark of the Quillaja saponaria (soap bark) evergreen tree native to central Chile.
When evaluating a vaccine for safety and effectiveness, FDA considers adjuvants as a component of the vaccine; they are not approved separately.
Certain antibiotics may be used in some vaccine production to help prevent bacterial contamination during manufacturing. As a result, small amounts of antibiotics may be present in some vaccines. Because some antibiotics can cause severe allergic reactions in those children allergic to them (such as hives, swelling at the back of the throat, and low blood pressure), some parents are concerned that antibiotics contained in vaccines might be harmful. However, antibiotics most likely to cause severe allergic reactions (e.g., penicillins, cephalosporins and sulfa drugs) are not used in vaccine production, and therefore are not contained in vaccines.
Examples of antibiotics used during vaccine manufacture include neomycin, polymyxin B, streptomycin and gentamicin. Some antibiotics used in vaccine production are present in the vaccine, either in very small amounts or they are undetectable. For example, antibiotics are used in some production methods for making inactivated influenza virus vaccines. They are used to reduce bacterial growth in eggs during processing steps, because eggs are not sterile products. The antibiotics that are used are reduced to very small or undetectable amounts during subsequent purification steps. The very small amounts of antibiotics contained in vaccines have not been clearly associated with severe allergic reactions.
In the manufacture of viral vaccines, the virus may be grown in cells. These cells need a source of nutrition, which in some instances may be provided by fetal bovine serum.